Ross J A, Isaacs S L
Center for Population and Family Health, Columbia University, New York, NY 10032.
Stud Fam Plann. 1988 Sep-Oct;19(5):270-83.
Anxieties about financing health and family planning programs have grown in recent years, leading to discussions of cost-recovery measures that would raise charges to the consumer. Yet some governments wish to lower cost to encourage contraceptive use, and a few use incentives and disincentives. Data from numerous developing countries are presented on contraceptive cost topics: charges for contraceptive supplies and services, in both public and private sectors, and conversely, payments made to clients and providers to offset costs and to increase contraceptive use. The data show great diversity, and much inconsistency within countries, indicating that the structures of charges, payments, and incentives in many programs could be improved. Ethical considerations are discussed, and guidelines are suggested for developing effective financial policies.
近年来，对卫生和计划生育项目融资的担忧日益增加，引发了关于成本回收措施的讨论，这些措施将提高对消费者的收费。然而，一些政府希望降低成本以鼓励使用避孕药具，还有一些政府使用激励和抑制措施。本文呈现了众多发展中国家关于避孕药具成本主题的数据：公共和私营部门避孕药具供应和服务的收费情况，以及相反地，为抵消成本和增加避孕药具使用而向客户和提供者支付的款项。数据显示出极大的多样性，且在各国国内也存在诸多不一致之处，这表明许多项目中的收费、支付和激励结构有待改进。文中讨论了伦理考量，并为制定有效的财政政策提出了指导方针。
